Macular degeneration trials in Australia

In Australia 19 Also abroad 218

19 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Where
Albury, East Melbourne, Parramatta, Strathfield
Age
50 years and over
People
272 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07441642 · EU 2025-523704-77-00
Phase 3Taking people
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Where
Adelaide, Albury, East Melbourne, Hurstville, Strathfield
Age
50 years to 85 years
People
975 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06541704 · EU 2023-509547-27-00
Phase 2/3Taking people
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Where
East Melbourne, Strathfield, Sydney, Westmead
Age
60 years and over
People
274 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06635148 · EU 2022-500747-21-00
No phaseTaking people
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
Where
Adelaide
Age
50 years and over
People
1,000 worldwide
Run by
University of Wisconsin, Madison
See details and how to joinNCT06924021
Phase 3Taking people
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Where
Albury, Hurstville
Age
50 years and over
People
1,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT03683251 · EU 2023-507131-38-00
Phase 1/2Taking people
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Where
Adelaide, East Melbourne, Sydney
Age
60 years and over
People
104 worldwide
Run by
Sanofi
See details and how to joinNCT07215234
Phase 3Taking people
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Where
Adelaide, Albury, Strathfield, Sydney
Age
50 years and over
People
480 worldwide
Run by
4D Molecular Therapeutics
See details and how to joinNCT07064759
Phase 2/3Taking people
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Where
Albury, Hurstville, Hurstville, Sydney, Launceston, Norwest, Parramatta, Strathfield, Sydney
Age
50 years and over
People
960 worldwide
Run by
EyeBiotech Ltd.
See details and how to joinNCT07440225
Phase 2Enrolling by invitation
ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study
Where
Melbourne E.
Age
55 years and over
People
225 worldwide
Run by
Gyroscope Therapeutics Limited
See details and how to joinNCT05481827 · EU 2024-510946-15-00
Phase 1/2Taking people
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Where
Albury, Baulkham Hills, East Melbourne, Hurstville, Rowville, Sydney
Age
55 years and over
People
152 worldwide
Run by
Biojiva LLC
See details and how to joinNCT07029945
Phase 2Taking people
A Study in Adults With Geographic Atrophy
Where
Adelaide, East Melbourne, Parkville, South Brisbane, Sydney, Westmead
Age
60 years and over
People
300 worldwide
Run by
Sitala Bio LTD
See details and how to joinNCT07606365 · EU 2026-525738-40-00
Phase 1/2Not yet taking people in Australia
First in Human Study of BETA-TT8 in wetAge-related Macular Degeneration (wetAMD)
Where
East Melbourne, Gosford, Sydney, Westmead
Age
50 years and over
People
24
Run by
Filamon LTD
See details and how to joinNCT07766473
Phase 2Taking people
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Where
Albury, East Melbourne, Hurstville, Malvern, Parramatta, Rowville, Sutherland, Sydney
Age
60 years and over
People
240 worldwide
Run by
ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06990269 · EU 2025-521779-30-00
No phaseTaking people
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Where
East Melbourne
Age
60 years and over
People
100 worldwide
Run by
i-Lumen Scientific AUS PTY LTD
See details and how to joinNCT06662162
Phase 1/2Taking people
A Study to Evaluate the Safety and Effect of TO-O-1007 Intravitreal Implant in Subjects With Geographic Atrophy
Where
Hurstville, Launceston, Sydney
Age
50 years and over
People
31
Run by
Theratocular Biotek Co.
See details and how to joinNCT07668804
Phase 1Taking people
Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
Where
Sydney
Age
50 years and over
People
18
Run by
Benobio Co., Ltd.
See details and how to joinNCT05803785
No phaseTaking people
Defining Retinal Structures Using Hyperspectral Retinal Imaging
Where
Melbourne
Age
18 years and over
People
1,000
Run by
Center for Eye Research Australia
See details and how to joinNCT07555574
No phaseNot yet taking people in Australia
Functional Assessments in Vision Impairment
Where
Melbourne
Age
18 years and over
People
45
Run by
Center for Eye Research Australia
See details and how to joinNCT06908161
No phaseTaking people
Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression
Where
East Melbourne
Age
18 years and over
People
2,500
Run by
Center for Eye Research Australia
See details and how to joinNCT04739319